Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/29/2871159/0/en/Pasithea-Therapeutics-Announces-PAS-004-Abstract-Accepted-for-Poster-Presentation-at-2024-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/24/2868521/0/en/Pasithea-Therapeutics-Announces-the-First-Cohort-has-Completed-the-Initial-Dosing-in-its-Phase-1-Trial-Evaluating-PAS-004-in-RAS-NF1-and-RAF-Mutated-Cancers.html
https://www.globenewswire.com//news-release/2024/01/08/2805360/0/en/Pasithea-Therapeutics-Announces-Invention-of-Crystalline-Form-of-PAS-004-Establishes-Strengthened-Intellectual-Property-IP-Position.html
https://www.globenewswire.com//news-release/2023/12/28/2801868/0/en/Pasithea-Therapeutics-Announces-Adjournment-of-Reconvened-Meeting-of-Stockholders-to-December-29-2023.html
https://www.globenewswire.com//news-release/2023/12/19/2798936/0/en/Pasithea-Therapeutics-Announces-Results-from-2023-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/12/11/2793833/0/en/Pasithea-Therapeutics-Announces-Positive-In-Vivo-Preclinical-Efficacy-Data-for-PAS-004-from-NRAS-Mutation-Cancer-Xenograft-Models.html
https://www.globenewswire.com//news-release/2023/09/14/2743251/0/en/Pasithea-Therapeutics-Corp-Announces-Final-Results-of-Tender-Offer.html
https://www.globenewswire.com//news-release/2023/09/07/2739785/0/en/Pasithea-Therapeutics-to-Participate-in-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html
https://www.globenewswire.com/news-release/2023/08/01/2715739/0/en/Pasithea-Therapeutics-publishes-study-in-Proceedings-of-the-National-Academy-of-Sciences-PNAS-that-shows-an-increase-in-%CE%B15-integrin-expression-in-ALS-human-and-mouse-brain-tissue-a.html
https://www.globenewswire.com/news-release/2023/07/20/2708213/0/en/Pasithea-Therapeutics-Announces-Intention-to-Commence-a-4-0-Million-Tender-Offer-for-its-Common-Stock-at-Price-of-0-70-per-Share-in-Cash.html